US BANCORP \DE\ - ALLIQUA BIOMEDICAL INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ALLIQUA BIOMEDICAL INC
ValueSharesWeighting
Q3 2017$52,000
-27.8%
143,422
-25.9%
0.00%
Q2 2017$72,000
-22.6%
193,422
+5.1%
0.00%
Q1 2017$93,000
-14.7%
184,0260.0%0.00%
Q4 2016$109,000
-24.8%
184,026
+1.3%
0.00%
-100.0%
Q3 2016$145,000
-28.9%
181,7320.0%0.00%0.0%
Q2 2016$204,000
+77.4%
181,732
+29.8%
0.00%
Q1 2016$115,000
-46.3%
140,000
+40.0%
0.00%
-100.0%
Q4 2015$214,000
+68.5%
100,000
+150.0%
0.00%0.0%
Q3 2015$127,000
-39.8%
40,0000.0%0.00%0.0%
Q2 2015$211,00040,0000.00%
Other shareholders
ALLIQUA BIOMEDICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 583,026$466,0000.14%
SUFFOLK CAPITAL MANAGEMENT LLC 1,264,101$1,011,0000.14%
Perceptive Advisors 1,921,951$1,537,0000.10%
Tekla Capital Management LLC 1,650,000$1,287,0000.05%
SABBY MANAGEMENT, LLC 1,321,726$1,031,0000.04%
J. Goldman & Co LP 540,000$432,0000.02%
Chicago Partners Investment Group LLC 6,453$5,0000.00%
Edge Wealth Management LLC 4,930$4,0000.00%
Janney Montgomery Scott LLC 98,000$78,0000.00%
US BANCORP \DE\ 181,732$145,0000.00%
View complete list of ALLIQUA BIOMEDICAL INC shareholders